Christopher Maxwell Fullerton, Director at Paradigm Biopharmaceuticals Ltd., holds 1.07M shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF), holds 254.06K shares in XTEK Limited (Ticker: AU:HCL), holds 0.00 shares in Life (Ticker: CORFF). Most recently, Christopher Maxwell Fullerton Bought ― shares of Paradigm Biopharmaceuticals Ltd. on Nov 19, 2019 for an estimated value of 301.05K.
What is the percentage of profitable transactions made by Christopher Maxwell Fullerton?
The percentage of profitable transactions made by Christopher Maxwell Fullerton is 100%.
What is the average return per transaction made by Christopher Maxwell Fullerton?
The average return per transaction made by Christopher Maxwell Fullerton is 128.40%.
What stocks does Christopher Maxwell Fullerton hold?
Christopher Maxwell Fullerton holds: PBIGF, AU:HCL, CORFF, AU:EGL, BNOX stocks.
What was Christopher Maxwell Fullerton’s latest transaction?
Christopher Maxwell Fullerton latest transaction was an Informative Buy of $301.05K.
What was Christopher Maxwell Fullerton's most profitable transaction?
Christopher Maxwell Fullerton’s most profitable transaction was an Informative Buy of PBIGF stock on July 3, 2019. The return on the trade was 136.60%.
What is Christopher Maxwell Fullerton's role in Paradigm Biopharmaceuticals Ltd.?
Christopher Maxwell Fullerton's role in Paradigm Biopharmaceuticals Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.